← Back to Screener
CapsoVision, Inc. Common Stock (CV)
Price$6.83
Value ScoreF
Growth ScoreD
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)16.40%
Price vs S&P 500 (4W)-7.92%
VGM Score38.70
Market Capitalization$342.25M
All Metrics
Book Value / Share (Quarterly)$0.41
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.48
Price vs S&P 500 (YTD)-47.31%
Gross Margin (TTM)51.67%
Net Profit Margin (TTM)-198.87%
EPS (TTM)$-0.58
10-Day Avg Trading Volume0.08M
EPS Excl Extra (TTM)$-0.58
EPS (Annual)$-1.03
ROI (Annual)-190.91%
Gross Margin (Annual)52.92%
Cash / Share (Quarterly)$0.36
Revenue Growth QoQ (YoY)0.32%
ROA (Last FY)-139.37%
EBITD / Share (TTM)$-0.58
Operating Margin (TTM)-200.74%
Cash Flow / Share (Annual)$-0.49
P/B Ratio16.93x
P/B Ratio (Quarterly)17.97x
Net Income / Employee (Annual)$-904,100
EV / Revenue (TTM)23.91x
ROA (TTM)-136.03%
EPS Incl Extra (Annual)$-1.03
Current Ratio (Annual)3.77x
Quick Ratio (Quarterly)3.82x
3-Month Avg Trading Volume0.27M
Revenue / Employee (TTM)$484,400
P/S Ratio (Annual)25.25x
Asset Turnover (Annual)0.75x
52-Week High$15.37
EPS Excl Extra (Annual)$-1.03
26-Week Price Return29.98%
Quick Ratio (Annual)2.95x
13-Week Price Return27.09%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.57x
Enterprise Value$324.32M
Asset Turnover (TTM)0.68x
Revenue / Employee (Annual)$484,100
Pretax Margin (Annual)-186.59%
Cash / Share (Annual)$0.22
3-Month Return Std Dev92.21%
Net Income / Employee (TTM)$-963,300
ROE (Last FY)-190.91%
EPS Basic Excl Extra (Annual)$-1.03
Receivables Turnover (TTM)7.62x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.58
ROI (TTM)-181.15%
P/S Ratio (TTM)25.23x
Revenue / Share (Annual)$0.55
Year-to-Date Return-35.92%
5-Day Price Return1.63%
EPS Normalized (Annual)$-1.03
Net Profit Margin (Annual)-186.77%
Month-to-Date Return1.03%
EBITD / Share (Annual)$-1.03
Operating Margin (Annual)-188.25%
EPS Basic Excl Extra (TTM)$-0.58
P/B Ratio (Annual)37.76x
Inventory Turnover (TTM)1.92x
Pretax Margin (TTM)-198.69%
Book Value / Share (Annual)$0.28
Price vs S&P 500 (13W)16.42%
Beta-1.43x
Revenue / Share (TTM)$0.29
ROE (TTM)-184.24%
52-Week Low$3.43
vGradeF
gGradeD
mGradeB
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.15est. -0.13
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.20
4.20
4.20
4.20
Industry Peers — Electromedical Equipment(31)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CVCapsoVision, Inc. Common Stock | F | D | B | $6.83 |
| MDTMedtronic plc | B | D | D | $77.95 |
| MASIMasimo Corporation | D | D | B | $178.78 |
| LIVNLivaNova PLC Ordinary Shares | C | C | B | $71.33 |
| ITGRInteger Holdings Corporation | B | C | C | $90.89 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | F | $69.69 |
| AXGNAxogen, Inc. Common Stock | F | B | A | $40.63 |
| BLFSBioLife Solutions Inc. | F | B | B | $27.25 |
| CNMDCONMED Corporation | A | C | D | $33.06 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | $13.49 |
| CBLLCeriBell, Inc. Common Stock | D | A | C | $17.18 |
About
CapsoVision develops ingestable capsule endoscopy technology for gastrointestinal imaging, enabling earlier detection of colorectal cancer and other GI diseases. The company's platform features multi-camera capsules with LED illumination, onboard memory, and extended battery life for comprehensive visualization. Current commercial product CapsoCam Plus targets the small intestine, while CapsoColon 3D is in development for large intestine imaging.